VSN Pharmaceuticals Private Limited
About VSN Pharmaceuticals Private Limited
Data last updated:
VSN Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2013PTC196529.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors including Suresh Kumar Agarwal and Nishant Chokhani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6 Thakur Bari Road, Kolkata, West Bengal, India – 700026.
As per the financials filed for FY 2025, the company reported a revenue of ₹45,110. For the same year it recorded a net profit of ₹12,760 (net margin 28.3%) and EBITDA of ₹17,060 (EBITDA margin 37.8%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 40% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
VSN Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6 Thakur Bari Road, Kolkata, West Bengal, India – 700026
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of VSN Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of VSN Pharmaceuticals Private Limited
FY 2025 filings availableVSN Pharmaceuticals Private Limited reported revenue of ₹45,110 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 40% over five years. EBITDA rose 134% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17,060 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12,760 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.8% | ||||
| Net Profit Margin | 28.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VSN Pharmaceuticals Private Limited, buy the company report.
Board of directors of VSN Pharmaceuticals Private Limited
VSN Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Agarwal Also directs: Manshya Agro Private Limited | Director | 16 Aug 2013 | 13 Years 2 Months | Current |
| Nishant Chokhani | Director | 16 Aug 2013 | 13 Years 2 Months | Current |
| Sadhan Roy | Director | 19 Aug 2013 | 13 Years 2 Months | Current |
| Vineet Kothari Also directs: Nu Sri Shyam Healthcare LLP | Director | 16 Aug 2013 | 13 Years 2 Months | Current |
Auditor
VSN Pharmaceuticals Private Limited is audited by Saraf Manoj & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Saraf Manoj & Co. | FY 2023 | 323473E |
Shareholding
The shareholding of VSN Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of VSN Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving VSN Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VSN Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for VSN Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
VSN Pharmaceuticals Private Limited has 4 board changes on record since 2013: 4 appointments. The latest: Sadhan Roy was appointed as Director on 19 Aug 2013.
Frequently asked questions
VSN Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 August 2013 (13+ years old) and is registered under CIN U51909WB2013PTC196529.
VSN Pharmaceuticals has 4 current directors:
- Suresh Kumar Agarwal - Director
- Nishant Chokhani - Director
- Sadhan Roy - Director
- Vineet Kothari - Director
The latest financial statements of VSN Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of VSN Pharmaceuticals is U51909WB2013PTC196529. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VSN Pharmaceuticals was incorporated on 16 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
Sadhan Roy was appointed as Director on 19 Aug 2013. Nishant Chokhani was appointed as Director on 16 Aug 2013. Suresh Kumar Agarwal was appointed as Director on 16 Aug 2013. VSN Pharmaceuticals has 4 board changes on record in total.
The registered office of VSN Pharmaceuticals is at 6 Thakur Bari Road, Kolkata, West Bengal, India – 700026.
VSN Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of VSN Pharmaceuticals is compliant as of 10 August 2026. The company is actively filing with the Registrar of Companies.
VSN Pharmaceuticals can be reached at its registered office: 6 Thakur Bari Road, Kolkata, West Bengal, India – 700026.